Ratings Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Market Closed - London Stock Exchange Other stock markets 11:35:13 2023-12-08 am EST			5-day change	1st Jan Change
180.9 ^GBX	-0.88%		-0.88%	-93.73%

Nov. 17	Shore cuts Sage; Barclays raises NatWest	AN
Nov. 15	Synthomer trading consistent with expectations	AN

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

The stock, which is currently worth 2023 to 0.45 times its sales, is clearly overvalued in comparison with peers.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
The group shows a rather high level of debt in proportion to its EBITDA.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector : Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
SYNTHOMER PLC	-93.73%	371 M $	B
ECOLAB INC.	+31.99%	54 781 M $	A-
SIKA AG	+10.83%	44 740 M $	A-
GIVAUDAN SA	+19.73%	35 528 M $	B+
EMS-CHEMIE HOLDING AG	+4.55%	17 377 M $	C+
SYMRISE AG	+3.64%	15 832 M $	B+
ALBEMARLE CORPORATION	-40.98%	15 020 M $	C+
NITTO DENKO CORPORATION	+31.05%	9 877 M $	A-
EVONIK INDUSTRIES AG	-2.51%	8 760 M $	A
CRODA INTERNATIONAL PLC	-27.82%	8 278 M $	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes